Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$344,236
+$80,263 QoQ
Shares Held
287
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#4,060
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Front Row Advisors LLC holds $11,088,191 across 9 Drug Manufacturers - General names. LLY ranks #4 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
24,207 | $6,091,449 | |
| 2 | AMGN |
Amgen Inc
|
8,625 | $3,123,285 | |
| 3 | JNJ |
Johnson & Johnson
|
4,871 | $1,237,087 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
287 | $344,236 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,497 | $189,130 | |
| 6 | PFE |
Pfizer Inc
|
2,210 | $53,216 | |
| 7 | MRK |
Merck & Co., Inc.
|
297 | $38,164 | |
| 8 | GSK |
GSK plc
|
221 | $11,584 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $344,236 | 287 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $263,973 | 287 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $303,059 | 282 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $215,166 | 282 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $225,284 | 289 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $250,250 | 303 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $233,916 | 303 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $268,439 | 303 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,146,211 | 1,266 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $1,179,387 | 1,516 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $322,354 | 553 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $813,751 | 1,515 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $660,323 | 1,408 | Shares | Sole | 2023-08-15 | |
| 2022-12-31 | $495,713 | 1,355 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $449,456 | 1,390 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $451,976 | 1,394 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $399,199 | 1,394 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $386,431 | 1,399 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $323,238 | 1,399 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $321,098 | 1,399 | Shares | Sole | 2021-08-23 | |
| 2021-03-31 | $261,361 | 1,399 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $236,544 | 1,401 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $207,376 | 1,401 | Shares | Sole | 2020-11-30 | |
| 2020-06-30 | $282,717 | 1,722 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $238,875 | 1,722 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||